Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.
Sign up for the Good Day BIO Newsletter >
June 3-6, 2024 | San Diego, CA
October 17-18, 2023 | San Francisco, CA
October 23-25, 2023 | Washington, DC
November 13-15, 2023 | New Orleans, LA
Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.
Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.
Bringing you daily news at the intersection of biotechnology, politics, patients & the planet.
BIO submitted general comments and specific recommendations to the FDA in response to the agency's request for information. (Docket FDA-2022-D-2870)
.png){kind=logo}
BIO submitted general comments and specific recommendations to the FDA in response to the agency's request for information. (Docket FDA-2022-D-2870)